A groundbreaking blood test could enable doctors to identify failing prostate cancer treatment earlier, a trial found.
Experts believe this discovery could lead to personalised therapies and extend the lives of men with advanced disease.
A groundbreaking blood test could enable doctors to identify failing prostate cancer treatment earlier, a trial found.
Experts believe this discovery could lead to personalised therapies and extend the lives of men with advanced disease.